Definition and epidemiology
ADHD is a persistent neurodevelopmental disorder marked by developmentally inappropriate levels of inattention, hyperactivity, and impulsivity. The DSM-5 recognizes three presentations: predominantly inattentive, predominantly hyperactive-impulsive, and combined type.
ADHD affects approximately 5-10% of children and adolescents globally, with prevalence varying by diagnostic criteria and assessment methods. Boys are diagnosed 2-3 times more frequently than girls, though this ratio narrows in adulthood as inattentive presentations (more common in females) are increasingly recognized. Approximately 60-70% of childhood cases persist into adulthood, affecting 2.5-5% of adults. Diagnosis rates have increased over recent decades, reflecting improved awareness and diagnostic practices rather than true prevalence changes.
- ADHD diagnosis requires symptoms present before age 12 in two or more settings causing functional impairment.
- Predominantly inattentive type is more common in girls and often diagnosed later than combined or hyperactive types.
- Stimulant medications (methylphenidate, amphetamines) are first-line pharmacotherapy with 70-80% response rates.
- Behavioral therapy alone is first-line for preschool children (age <6); combination therapy for school-age and older.
- ADHD has 70-80% heritability; first-degree relatives have 4-5 times increased risk.
- Comorbidities occur in 60-80% of cases; oppositional defiant disorder and anxiety disorders are most common.
- Approximately 60-70% of childhood ADHD persists into adulthood; hyperactivity decreases but inattention remains.
- Stimulant treatment reduces risk of substance use disorders; does not cause addiction when used appropriately.
Etiology and risk factors
ADHD has a strong genetic component with heritability estimates of 70-80%. Multiple genes involved in dopaminergic and noradrenergic neurotransmission contribute to susceptibility, including variations in dopamine receptor D4 (DRD4) and dopamine transporter (DAT1) genes.
Risk factors include:
- Genetic: First-degree relatives have 4-5 times increased risk
- Prenatal exposures: Maternal smoking, alcohol use, extreme stress during pregnancy
- Perinatal factors: Prematurity, low birth weight, perinatal hypoxia
- Environmental toxins: Lead exposure, certain pesticides
- Psychosocial adversity: Not causative but may worsen symptoms or complicate diagnosis
Controversies around dietary factors (sugar, food additives) lack strong evidence. ADHD is not caused by poor parenting, excessive screen time, or vaccines, though environmental factors may influence symptom expression in genetically susceptible individuals.
Pathophysiology
ADHD involves dysfunction in prefrontal cortex networks responsible for executive functions including attention regulation, impulse control, and working memory. Neuroimaging studies demonstrate reduced volume in prefrontal cortex, basal ganglia, and cerebellum, with delayed cortical maturation patterns.
Neurotransmitter dysfunction
The primary pathophysiology involves dysregulation of catecholamine neurotransmission, particularly dopamine and norepinephrine. Reduced dopaminergic activity in frontostriatal circuits impairs reward processing and motivation. Noradrenergic dysfunction in prefrontal cortex affects attention and executive control.
Neural network abnormalities
Functional connectivity studies show altered activity in:
- Default mode network: Fails to appropriately deactivate during tasks requiring attention
- Attention networks: Reduced activation in dorsal attention network
- Reward circuits: Blunted striatal responses to rewards, contributing to impulsivity and delay aversion
These neurobiological alterations explain the core symptom triad and the therapeutic efficacy of medications that enhance catecholamine transmission.
Clinical features
ADHD symptoms must be present before age 12, occur in two or more settings, and cause significant functional impairment. The presentation varies by age and subtype.
Inattention symptoms
- Difficulty sustaining attention in tasks or play
- Frequent careless mistakes, overlooking details
- Appears not to listen when spoken to directly
- Fails to follow through on instructions, leaves tasks unfinished
- Difficulty organizing tasks and activities
- Avoids tasks requiring sustained mental effort
- Frequently loses necessary items
- Easily distracted by extraneous stimuli
- Forgetful in daily activities
Hyperactivity-impulsivity symptoms
- Fidgets, taps hands or feet, squirms in seat
- Leaves seat when remaining seated is expected
- Runs or climbs inappropriately (restlessness in adults)
- Unable to engage quietly in leisure activities
- "On the go" or "driven by a motor"
- Talks excessively
- Blurts out answers before questions completed
- Difficulty waiting turn
- Interrupts or intrudes on others
Age-specific presentations
Preschool children: Predominantly hyperactive-impulsive symptoms, constant motion, difficulty with quiet activities, aggressive behavior.
School-age children: Combined presentation most common; academic difficulties, peer relationship problems, oppositional behavior.
Adolescents: Hyperactivity decreases but inattention persists; academic underachievement, risk-taking behaviors, low self-esteem.
Adults: Internal restlessness rather than overt hyperactivity; chronic disorganization, procrastination, job instability, relationship difficulties.
Comorbidities occur in 60-80% of cases, including oppositional defiant disorder (50%), anxiety disorders (30-40%), mood disorders (15-20%), learning disabilities (30-50%), and substance use disorders (higher in adolescents/adults).
Diagnosis
ADHD diagnosis is clinical, based on history and behavioral observations. No laboratory test or neuroimaging confirms the diagnosis.
Diagnostic criteria (DSM-5)
For children: Six or more symptoms of inattention and/or hyperactivity-impulsivity present for at least 6 months.
For adolescents and adults (age ≥17): Five or more symptoms required.
Symptoms must:
- Be present before age 12
- Occur in two or more settings
- Interfere with social, academic, or occupational functioning
- Not be better explained by another mental disorder
Assessment process
Clinical interview: Detailed developmental history, symptom onset and duration, functional impairment across settings.
Rating scales: Conners Rating Scales, Vanderbilt Assessment Scales, ADHD Rating Scale-5 completed by parents and teachers provide standardized symptom assessment.
Collateral information: Essential to obtain reports from multiple settings (school, work, home).
Psychological testing: Not required for diagnosis but may identify learning disabilities or cognitive strengths/weaknesses. Continuous performance tests (CPT) lack diagnostic specificity.
Medical evaluation: Rule out hearing/vision problems, sleep disorders, thyroid dysfunction, anemia. Screen for comorbid conditions.
No routine laboratory tests or neuroimaging are indicated. EEG and brain imaging are not diagnostic tools for ADHD. Rating scales support but do not substitute for clinical judgment.
Differential diagnosis
Many conditions mimic ADHD or coexist with it, requiring careful evaluation.
| Condition | Distinguishing features |
|---|---|
| Normal developmental variation | Symptoms within age-appropriate range, no functional impairment |
| Learning disabilities | Inattention limited to academic tasks, normal attention in preferred activities |
| Intellectual disability | Global cognitive delays, attention problems proportionate to developmental level |
| Autism spectrum disorder | Restricted interests, social communication deficits, stereotyped behaviors |
| Anxiety disorders | Inattention due to worry, improves when anxiety treated |
| Depression | Anhedonia, mood changes, late onset of concentration problems |
| Bipolar disorder | Episodic symptoms, distinct mood episodes with irritability |
| Sleep disorders | Daytime sleepiness, snoring, witnessed apneas; improves with sleep treatment |
| Substance use | Temporal relationship with substance use, no childhood symptoms |
| Thyroid disorders | Abnormal thyroid function tests, other systemic symptoms |
| Medication effects | Temporal relationship with medication (e.g., anticonvulsants, corticosteroids) |
| Oppositional defiant disorder | Defiance and negativity rather than inability to focus |
| Trauma/PTSD | History of trauma, hypervigilance, re-experiencing symptoms |
Comorbidities are common and do not exclude ADHD diagnosis. Systematic assessment for coexisting conditions is essential for comprehensive treatment planning.
Management
ADHD management is multimodal, combining behavioral interventions and pharmacotherapy tailored to age, symptom severity, and functional impairment.
Non-pharmacological interventions
Behavioral therapy: Evidence-based parent training (e.g., parent management training, behavioral parent training) teaches contingency management and positive reinforcement strategies. Teacher-implemented classroom behavior management improves academic performance.
Psychoeducation: Essential for patients, families, and teachers to understand ADHD as a neurobiological condition.
School accommodations: 504 plans or IEPs may include preferential seating, extended time on tests, reduced distractions, organizational supports.
Lifestyle modifications: Regular sleep schedule, physical exercise, structured routines, reduced screen time support symptom management.
Pharmacological treatment
Stimulant medications are first-line pharmacotherapy with 70-80% response rates.
Methylphenidate formulations: Act by blocking dopamine and norepinephrine reuptake. Available in short-acting (immediate-release), intermediate-acting, and long-acting preparations.
Amphetamine formulations: Promote dopamine and norepinephrine release and block reuptake. Multiple formulations available with varying durations.
Common side effects include appetite suppression, insomnia, headache, abdominal pain. Monitor growth, blood pressure, and heart rate. Stimulants are controlled substances but abuse risk is low when used appropriately.
Non-stimulant medications are alternatives for inadequate response, intolerable side effects, or contraindications to stimulants.
Atomoxetine: Selective norepinephrine reuptake inhibitor. Takes 4-6 weeks for full effect. Lower abuse potential. Black box warning: Increased risk of suicidal ideation in children and adolescents; monitor closely, especially early in treatment.
Guanfacine and clonidine: Alpha-2 agonists, particularly helpful for hyperactivity and impulsivity. May cause sedation.
Bupropion: Norepinephrine-dopamine reuptake inhibitor, sometimes used off-label.
Treatment approach by age
Preschool (age <6 years): Behavioral therapy first-line. Methylphenidate considered if behavioral interventions insufficient and moderate-to-severe impairment.
School-age (6-11 years): Combination of behavioral therapy and medication recommended. Stimulants plus behavioral parent training most effective.
Adolescents (12-17 years): Medication often necessary; behavioral interventions adapted to developmental level.
Adults: Stimulants first-line; cognitive-behavioral therapy addresses organizational and coping skills.
Monitoring
Regular follow-up every 3-6 months to assess:
- Symptom improvement using rating scales
- Functional outcomes (academic, occupational, social)
- Medication side effects
- Height, weight, blood pressure, heart rate
- Comorbid conditions and substance use
Medication holidays are not routinely recommended but may be considered to reassess need or allow catch-up growth.
Complications and prognosis
Complications
Untreated or inadequately managed ADHD leads to multiple adverse outcomes:
Academic and occupational: School failure, grade retention, lower educational attainment, job instability, unemployment, reduced income.
Social and interpersonal: Peer rejection, social isolation, family conflict, higher divorce rates.
Mental health: Increased risk of anxiety, depression, low self-esteem, personality disorders.
Behavioral: Higher rates of oppositional defiant disorder, conduct disorder, antisocial behavior, criminality.
Substance use: 2-3 times increased risk of smoking, alcohol, and illicit drug use disorders. Treatment with stimulants reduces this risk.
Accidents and injuries: Higher rates of motor vehicle accidents, injuries, emergency department visits.
Health outcomes: Increased risk of obesity, sleep disorders, accidental injuries.
Prognosis
ADHD is a chronic condition. Approximately 60-70% of children continue to have symptoms and impairment in adulthood. Hyperactivity typically decreases with age, but inattention and executive dysfunction often persist.
Factors predicting better outcomes:
- Higher intelligence
- Absence of comorbid conduct disorder or learning disabilities
- Stable family environment
- Early diagnosis and appropriate treatment
- Good response to medication
Factors predicting worse outcomes:
- Comorbid psychiatric disorders
- Family adversity
- Low socioeconomic status
- Delayed or inadequate treatment
With appropriate multimodal treatment, most individuals with ADHD can achieve good functional outcomes. Early intervention improves long-term prognosis. Adults with ADHD benefit from continued treatment and may require ongoing support for organizational and executive function challenges. Regular monitoring and adjustment of treatment strategies optimize outcomes across the lifespan.
INATTENTION mnemonic for inattentive symptoms: I=Inattentive to details, N=Not listening, A=Avoids sustained effort, T=Trouble organizing, T=Tends to lose things, E=Easily distracted, N=Never finishes tasks, T=Trouble following instructions, I=Ignores daily activities, O=Often forgetful, N=Neglects to sustain attention.
Practice questions
1. A 7-year-old boy is brought to the clinic by his mother for poor school performance. His teacher reports that he frequently interrupts class, cannot stay in his seat, and fails to complete assignments despite normal intelligence. At home, he has difficulty waiting his turn during games and often loses his homework. Physical examination is unremarkable. Which of the following is the most appropriate initial management?
2. A 9-year-old girl with ADHD combined type has been taking methylphenidate for 6 months with good symptom control. Her mother reports that she has grown only 1 cm during this period and has lost 2 kg. Vital signs show blood pressure 118/76 mmHg and heart rate 88/min. Which of the following is the most appropriate next step?
3. A 28-year-old man presents reporting lifelong difficulty with organization, frequent job changes due to missing deadlines, and relationship problems from forgetting important dates. He was diagnosed with ADHD as a child but stopped medication at age 16. He denies current hyperactivity but describes constant internal restlessness. Which of the following best explains his current presentation?
Frequently asked questions
What causes ADHD?
ADHD results from genetic and neurobiological factors affecting brain development and neurotransmitter function, particularly dopamine and norepinephrine. It has 70-80% heritability with multiple genes involved. Prenatal exposures (maternal smoking, alcohol), prematurity, low birth weight, and lead exposure increase risk. ADHD is not caused by poor parenting, too much screen time, or diet, though these may influence symptom severity.
What are the first symptoms of ADHD?
The first symptoms typically appear in preschool or early school years as excessive motor activity, inability to sit still, constant talking, and impulsive behavior. Inattentive symptoms like difficulty following instructions, not listening, and being easily distracted become more apparent when school demands increase. Boys often show hyperactivity first, while girls may present with primarily inattentive symptoms that go unrecognized until later.
How is ADHD diagnosed?
ADHD is diagnosed clinically based on detailed history and behavioral observation. Diagnosis requires six or more symptoms of inattention and/or hyperactivity-impulsivity (five for ages 17+) present for at least 6 months, occurring before age 12, in two or more settings, causing functional impairment. Rating scales from parents and teachers support diagnosis. No laboratory test or brain imaging confirms ADHD.
Is ADHD curable?
ADHD is not curable but highly treatable. It is a chronic neurodevelopmental condition that persists into adulthood in 60-70% of cases. Treatment with stimulant medications and behavioral therapy significantly improves symptoms and functioning. While hyperactivity often decreases with age, inattention and executive function difficulties typically continue, requiring ongoing management strategies and sometimes lifelong treatment.
ADHD vs autism — what is the difference?
ADHD involves inattention, hyperactivity, and impulsivity affecting multiple settings, while autism spectrum disorder features social communication deficits, restricted interests, and repetitive behaviors. ADHD children have age-appropriate social interest but may struggle with impulse control; autistic children have difficulty understanding social cues and prefer routine. Both can coexist in the same individual. ADHD responds well to stimulants; autism treatment focuses on behavioral and developmental interventions.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F90.0
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.